II. Indications
- Thrombus Prophylaxis (e.g. DVT Prophylaxis after hip surgery)
- Unstable Angina
- Percutaneous Coronary Intervention (PCI)
- Heparin-Induced Thrombocytopenia
- Atrial Fibrillation
III. Dosing: Hirudins (bivalent peptide derivatives from Salivary Gland of medicinal leaches)
- Lepirudan (Refludan)
- See other references for dosing
-
Bivalirudin (Angiomax)
- Used in Unstable Angina if Heparin contraindicated
- Coadminister with Aspirin
- Initial: 0.75 mg/kg IV bolus
- Later: 1.75 mg/kg/hour for 4 hours
- Maintenance: 0.2 mg/kg/hour for up to 20 hours
-
Desirudin (Ipravask)
- DVT Prophylaxis: 15 mg SQ q12 hours after hip surgery
IV. Dosing: Non-Hirudans (Univalent agents)
-
Dabigatran (Pradaxa)
- See Dabigatran
-
Ximelagatran (Exanta, Exarta)
- No longer available in United States due to hepatotoxicity
-
Argatroban (Acova)
- Initial: 2 mcg/kg/minute
- Maintenance: Adjusted per PTT
V. Pharmacokinetics
- Clearance
- Renal Clearance for Hirudins
- Hepatic Clearance for L-Arginine derivatives
VI. Precautions
-
Allergic Reaction
- Serious Allergic Reactions including Anaphylaxis may occur with Hirudins
- Highest risk on Hirudin re-exposure or in GFR <30 ml/min
- Bleeding complications
- Epidural Hematoma
- High risk if Lumbar Puncture performed while on Direct Thrombin Inhibitors
- Epidural Hematoma
- No antidote for bleeding except for Dabigatran (all recommendations per expert opinion)
- Dabigatran (Pradaxa) has a specific antidote (Praxbind)
- Stop offending agent (most have short Half-Life such as 12-14 hours for Dabigatran)
- Bleeding unlikely due to Direct Thrombin Inhibitor if aPTT <37 seconds and Thrombin Time <25 seconds
- Consider Activated Charcoal if presenting within 2 hours of suspected Overdose ingestion
- Dialysis is unlikely to be beneficial
- Logistics of placing large bore filtered catheters in actively bleeding, coagulopathic patients
- Life threatening bleeding - reversal agents